Viatris, Inc. (VTRS)
16.54
+0.22
(+1.38%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Viatris 1 Year Total Returns (Daily) : 59.76% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 59.76% |
| August 20, 2026 | 57.24% |
| August 19, 2026 | 58.01% |
| August 18, 2026 | 58.02% |
| August 17, 2026 | 58.91% |
| August 14, 2026 | 57.72% |
| August 13, 2026 | 60.06% |
| August 12, 2026 | 65.27% |
| August 11, 2026 | 71.52% |
| August 10, 2026 | 74.35% |
| August 07, 2026 | 81.76% |
| August 06, 2026 | 93.40% |
| August 05, 2026 | 104.2% |
| August 04, 2026 | 105.7% |
| August 03, 2026 | 107.9% |
| July 31, 2026 | 108.7% |
| July 30, 2026 | 105.0% |
| July 29, 2026 | 101.4% |
| July 28, 2026 | 100.4% |
| July 27, 2026 | 94.68% |
| July 24, 2026 | 91.54% |
| July 23, 2026 | 91.58% |
| July 22, 2026 | 91.24% |
| July 21, 2026 | 105.3% |
| July 20, 2026 | 98.75% |
| Date | Value |
|---|---|
| July 17, 2026 | 93.75% |
| July 16, 2026 | 98.27% |
| July 15, 2026 | 94.04% |
| July 14, 2026 | 85.37% |
| July 13, 2026 | 86.69% |
| July 10, 2026 | 82.72% |
| July 09, 2026 | 83.90% |
| July 08, 2026 | 86.90% |
| July 07, 2026 | 91.50% |
| July 06, 2026 | 87.25% |
| July 02, 2026 | 85.74% |
| July 01, 2026 | 83.09% |
| June 30, 2026 | 84.73% |
| June 29, 2026 | 87.12% |
| June 26, 2026 | 86.01% |
| June 25, 2026 | 87.78% |
| June 24, 2026 | 84.90% |
| June 23, 2026 | 84.87% |
| June 22, 2026 | 80.12% |
| June 18, 2026 | 82.06% |
| June 17, 2026 | 86.54% |
| June 16, 2026 | 85.35% |
| June 15, 2026 | 90.06% |
| June 12, 2026 | 88.33% |
| June 11, 2026 | 88.68% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Pfizer Inc. | 16.73% |
| Eli Lilly & Co. | 77.98% |
| Merck & Co., Inc. | 83.18% |
| Bristol Myers Squibb Co. | 44.96% |
| Johnson & Johnson | 54.80% |